Tessari Eben sold KNSA
August 5, 2025 · Form 4 insider transaction
Tessari Eben sold 138,064 shares of Kiniksa Pharmaceuticals International, plc at $33.20 per share, a transaction worth $4.58M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
138,064
Price
$33.20
Total value
$4.58M
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateAugust 5, 2025
Filing dateAugust 7, 2025
Shares owned after50,465
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.83 and $33.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.